NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
31 March 2025
| Name: | IMMURON LIMITED (IMC) | ||||||
| ISIN: | AU000000IMC7 | ||||||
| Date of Listing: | 30 April 1999 | ||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This entity is currently listed and quoted on the Australian Securities Exchange.Legal Status: (updated monthly)
ACN: 063 114 045ABN: 80 063 114 045
Registration Date: 13 January 1994
Capital Gains Tax (CGT) Status: (updated at least quarterly)
To crystallise a capital gain or capital loss on your securities in this entity, you are able to sell your securities on-market in the normal manner. If you determine that the market in your securities is illiquid and you still wish to crystallise a capital gain or loss, kindly contact deListed at admin@delisted.com.au for suggestions as to how you might proceed.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| IMMURON LIMITED | 05/12/2008 | |
| ANADIS LIMITED | 05/12/2008 |
Automic Registry Pty Ltd
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail
Expand this box to read and print
The suspension of trading in the securities of Immuron Limited will be lifted from the commencement of trading on 24 September 2021, following the release by IMC of an announcement regarding a planned acquisition | 23/09/2021 |
The Company has been pursuing a major acquisition of a private biotechnology company focused on the development of innovative vaccine technologies. After filing with the ASX a detailed ASX In-Principal Advice Application and subsequent lengthy discussions and exchanges with the ASX. ASX advised Immuron that based on the information provided to date, ASX does not currently have sufficient information to enable it to be satisfied that the combined group after the proposed acquisition would meet those requirements under chapters 1 and 2 of the ASX Listing Rules. Immuron as a result is now unable to satisfy the pre-conditions for this proposed acquisition due to the expiration of the existing contractual timetable and will not proceed with the proposed acquisition in its present form. There are no break fees associated with being unable to satisfy the preconditions existing contractual timetable, however professional fees associated with thistransaction over the past 4 months are approximately $450k plus GST. | 23/09/2021 |
The company lodges its Preliminary Final Report. | 31/08/2021 |
Immuron is required to lodge a formal In-Principle Advice Application in accordance with Guidance Note 12. That application has now been received by ASX, and the ASX is currently considering the application in connection with Immuron's suitability for admission to the official list of ASX Limited. Immuron acknowledges that its securities will remain suspended until it has met the requirements set out in Guidance Note 12. | 07/07/2021 |
The company is limited in the detail that can be released at this time while the ASX consider a submission it has requested from the Company in relation to ASX Listing Rule 11.1 and 11.2 and Guidance Note 12. | 08/06/2021 |
The securities of Immuron Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of IMC, pending the release of an announcement regarding a planned acquisition. | 31/05/2021 |
we understand that on or about this date the company consolidated its shares 1 for 40 | 17/11/2014 |
The suspension of trading in the securities of Immuron Limited (the "Company") will be lifted immediately, following the release of an announcement of a capital raising. Security Code: IMC | 23/04/2012 |
The securities of Immuron Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising | 20/04/2012 |
name changed from Anadis Limited | 05/12/2008 |
The suspension of trading in the securities of Immuron Limited will be lifted from the commencement of trading on 24 September 2021, following the release by IMC of an announcement regarding a planned acquisition | 23/09/2021 |
The Company has been pursuing a major acquisition of a private biotechnology company focused on the development of innovative vaccine technologies. After filing with the ASX a detailed ASX In-Principal Advice Application and subsequent lengthy discussions and exchanges with the ASX. ASX advised Immuron that based on the information provided to date, ASX does not currently have sufficient information to enable it to be satisfied that the combined group after the proposed acquisition would meet those requirements under chapters 1 and 2 of the ASX Listing Rules. Immuron as a result is now unable to satisfy the pre-conditions for this proposed acquisition due to the expiration of the existing contractual timetable and will not proceed with the proposed acquisition in its present form. There are no break fees associated with being unable to satisfy the preconditions existing contractual timetable, however professional fees associated with thistransaction over the past 4 months are approximately $450k plus GST. | 23/09/2021 |
The company lodges its Preliminary Final Report. | 31/08/2021 |
Immuron is required to lodge a formal In-Principle Advice Application in accordance with Guidance Note 12. That application has now been received by ASX, and the ASX is currently considering the application in connection with Immuron's suitability for admission to the official list of ASX Limited. Immuron acknowledges that its securities will remain suspended until it has met the requirements set out in Guidance Note 12. | 07/07/2021 |
The company is limited in the detail that can be released at this time while the ASX consider a submission it has requested from the Company in relation to ASX Listing Rule 11.1 and 11.2 and Guidance Note 12. | 08/06/2021 |
The securities of Immuron Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of IMC, pending the release of an announcement regarding a planned acquisition. | 31/05/2021 |
we understand that on or about this date the company consolidated its shares 1 for 40 | 17/11/2014 |
The suspension of trading in the securities of Immuron Limited (the "Company") will be lifted immediately, following the release of an announcement of a capital raising. Security Code: IMC | 23/04/2012 |
The securities of Immuron Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising | 20/04/2012 |
name changed from Anadis Limited | 05/12/2008 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 30/06/2022 | Daniel Pollock | 50,000 | $0.076 | $3,800 |
| 20/11/2020 | Daniel Pollock | -100,000 | $0.260 | $26,000 |
| 23/06/2020 | Daniel Pollock | -100,000 | $0.325 | $32,500 |
| 17/06/2020 | Peter Anastasiou | -4,184,808 | $0.312 | $1,306,326 |
| 11/06/2020 | Daniel Pollock | -100,000 | $0.405 | $40,480 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Paul Brennan | Chairman | 16/03/2022 |
| Steven Lydeamore | CEO | 27/06/2022 |
| Jerry Kanellos | COO | 28/07/2015 |
| Daniel Pollock | Non Exec Director | 11/10/2012 |
| Jeannie Joughin | Non Exec Director | 01/06/2024 |
| Ravi Savarirayan | Director | 07/04/2017 |
| Phillip Hains | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Roger Aston | Non Exec Director | 25/05/2012 | 31/05/2024 |
| Steve Anastasiou | Non Exec Director | 28/05/2013 | 03/05/2024 |
| Peter Anastasiou | Vice Chairman | 21/05/2015 | 24/09/2021 |
| Gary Jacob | Managing Director, CEO | 19/11/2018 | 25/03/2020 |
| Richard Berman | Director | 01/07/2018 | 17/10/2019 |
| Thomas Liquard | CEO | 31/08/2015 | 03/08/2017 |
| Leearne Hinch | CEO | 02/04/2015 | 08/07/2015 |
| Amos Meltzer | CEO | 28/02/2013 | 02/04/2015 |
| Elane Zelcer | Deputy Chairman | 19/11/2009 | 02/09/2013 |
| Stewart Washer | Non Exec Director | 08/02/2012 | 03/07/2013 |
| Graeme Stevens | CFO | 22/11/2007 | 19/04/2013 |
| Joe Baini | Managing Director, CEO | 17/01/2011 | 28/02/2013 |
| Colin Chapman | Executive Chairman | 17/12/2008 | 08/10/2012 |
| Simon Salka | Non Exec Director | 18/06/2008 | 07/02/2012 |
| Roy Robins-Browne | Non Exec Director | 02/02/1998 | 07/02/2012 |
| Arie Nudel | Director | 12/07/2005 | 26/03/2010 |
| Zeil Rosenberg | Executive Director, CEO | 18/06/2008 | 19/07/2009 |
| Peter Jenkins | Non Exec Director | 17/01/1994 | 11/02/2009 |
| Roman Zwolenski | Chairman | 24/09/2002 | 20/06/2008 |
| Philip Molyneux | Non Exec Chairman | 15/01/1998 | 22/07/2007 |
| Conor Graham | Managing Director, CEO | 01/05/1997 | 14/04/2007 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
